19.3 ϫ 10 4 /mm 3 and a mild increase of histiocytes showing phagocytosis of neutrophils and erythroblasts (Figure 1 ). Although cultures for virus from her urine or throat were We report a 3-year-old girl with hemophagocytic lymphohistiocytosis (HLH) who received BMT from an negative, her serum anti-CMV titer (IgM) was raised. Serum soluble IL-2 receptor was elevated to 3173 U/ml, HLA-identical unrelated donor when the disease was active. She had entered remission in response to chemobut IFN-␥, tumor necrosis factor (TNF) and IL-6 were within the normal ranges. Serum ferritin was also normal. therapy consisting of etoposide and methylprednisolone. After a relapse, her disease became refractory to chemoWith a diagnosis of HLH associated with CMV infection, CMV hyperimmune␥-globulin (400 mg/kg/day for 5 contherapy, and splenectomy was performed with marginal improvement. She underwent BMT from an HLAsecutive days), acyclovir (30 mg/kg/day) and prednisolone (1 mg/kg/day) were administered ( Figure 2 ). She became identical unrelated donor, conditioned with CY, TBI and anti-thymocyte globulin (ATG). She has been in afebrile, but splenomegaly persisted and she required platelets at least twice a week. Since gancyclovir (10 mg/kg/day) complete remission for 18 months since the BMT. This result suggests that BMT from an HLA-identical unredid not improve her condition, etoposide (VP16) (100 mg/m 2 ), ␥-globulin (400 mg/kg) and methylprednisolated donor should be considered for HLH even if the disease is active.
Engraftment was achieved 6 months after BMT, and was
